MPXV Viral Clearance, Transmission Dynamics, and Vaccine Effectiveness Study in Guinea

NIH registered an observational clinical study on ClinicalTrials.gov focused on understanding Monkeypox virus dynamics in Guinea. The study has three objectives: examining MPXV elimination kinetics from human bodies (MOVIE-West Africa), determining transmission dynamics between cases and contacts (TRACE-West Africa), and evaluating MVA-BN vaccine effectiveness against MPXV infection and disease (VE-West Africa). The study is registered as observational with no stated completion date. This is a research registration with no compliance obligations or regulatory requirements for external parties.

Implications for affected parties are limited to the research community. Healthcare providers and public health authorities may reference future study findings for clinical decision-making, but this registration alone creates no new obligations or reporting requirements. The study's findings could inform public health strategies in outbreak regions but only after publication.